...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >MAPK phosphotase 5 deficiency contributes to protection against blood-stage plasmodium yoelii 17XL infection in mice
【24h】

MAPK phosphotase 5 deficiency contributes to protection against blood-stage plasmodium yoelii 17XL infection in mice

机译:MAPK磷酸酶5缺乏有助于保护小鼠血阶段约氏疟原虫17XL感染

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cell-mediated immunity plays a crucial role in the development of host resistance to asexual blood-stage malaria infection. However, little is known of the regulatory factors involved in this process. In this study, we investigated the impact of MAPK phosphotase 5 (MKP5) on protective immunity against a lethal Plasmodium yoelii 17XL blood-stage infection using MKP5 knockout C57BL/6 mice. Compared with wild-type control mice, MKP5 knockout mice developed significantly lower parasite burdens with prolonged survival times. We found that this phenomenon correlated with a rapid and strong IFN-g-dependent cellular immune response during the acute phase of infection. Inactivation of IFN-g by the administration of a neutralizing Ab significantly reduced the protective effects in MKP5 knockout mice. By analyzing IFN-g production in innate and adaptive lymphocyte subsets, we observed that MKP5 deficiency specifically enhanced the IFN-g response mediated by CD4+ T cells, which was attributable to the increased stimulatory capacity of splenic CD11c+ dendritic cells. Furthermore, following vaccination with whole blood-stage soluble plasmodial Ag, MKP5 knockout mice acquired strongly enhanced Ag-specific immune responses and a higher level of protection against subsequent P. yoelii 17XL challenge. Finally, we found the enhanced response mediated by MKP5 deficiency resulted in a lethal consequence in mice when infected with nonlethal P. yoelii 17XNL. Thus, our data indicate that MKP5 is a potential regulator of immune resistance against Plasmodium infection in mice, and that an understanding of the role of MKP5 in manipulating anti-malaria immunity may provide valuable information on the development of better control strategies for human malaria.
机译:细胞介导的免疫在宿主对无性血液阶段疟疾感染的抗性发展中起关键作用。但是,对该过程涉及的调控因素知之甚少。在这项研究中,我们调查了MAPK磷酸酶5(MKP5)对使用MKP5基因敲除C57BL / 6小鼠致死性约氏疟原虫17XL血液阶段感染的保护性免疫的影响。与野生型对照小鼠相比,MKP5基因敲除小鼠的寄生虫负担明显降低,存活时间延长。我们发现,这种现象与感染急性期快速而强烈的依赖于IFN-g的细胞免疫反应有关。通过施用中和的Ab使IFN-g失活显着降低了对MKP5敲除小鼠的保护作用。通过分析先天性和适应性淋巴细胞亚群中的IFN-g产生,我们观察到MKP5缺乏特异性增强了CD4 + T细胞介导的IFN-g应答,这归因于脾CD11c +树突状细胞的刺激能力增强。此外,在接种全血阶段可溶性疟原虫Ag后,MKP5基因敲除小鼠获得了大大增强的Ag特异性免疫反应,并获得了更高水平的针对随后的约氏疟原虫17XL攻击的保护。最后,我们发现由MKP5缺乏症介导的增强反应在感染非致死性约氏疟原虫17XNL的小鼠中造成致命后果。因此,我们的数据表明MKP5是小鼠抗疟原虫感染免疫抵抗的潜在调节剂,并且对MKP5在控制抗疟疾免疫中的作用的理解可能为开发更好的人类疟疾控制策略提供有价值的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号